Adma Biologics (ADMA)
19.03 x 1 19.52 x 6
Post-market by (Cboe BZX)
19.45 -0.78 (-3.86%) 04/03/25 [NASDAQ]
19.03 x 1 19.52 x 6
Post-market 19.04 -0.41 (-2.11%) 16:20 ET
for Thu, Apr 3rd, 2025
Results
download Want to compare other data? Select Fields| Symbol | ADMA | VRNA | CYTK | ||
| Company | Adma Biologics | Verona Pharma Plc ADR | Cytokinetics | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 19.25 | 57.42 | 39.43 | ||
| High | 19.78 | 59.25 | 42.37 | ||
| Low | 19.23 | 56.71 | 39.43 | ||
| Last | 19.45 | 58.09 | 40.52 | ||
| Change | -0.78 | -2.20 | +0.27 | ||
| % Change | -3.86% | -3.65% | +0.67% | ||
| Volume | 2,259,739 | 1,670,457 | 2,740,566 | ||
| 20-Day Average Volume | 3,284,487 | 1,252,388 | 1,963,673 | ||
| Previous Close | 20.23 | 60.29 | 40.25 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 19.15 | 63.85 | 43.17 | ||
| 20-Day Raw Stochastic | 74.07% | 20.56% | 27.89% | ||
| 20-Day Relative Strength | 55.52% | 44.57% | 42.19% | ||
| Weighted Alpha | +111.34 | +210.14 | -44.09 | ||
| Today's Opinion | 72% Buy | 56% Buy | 100% Sell | ||
| Previous Opinion | 72% Buy | 64% Buy | 100% Sell | ||
| Last Month's Opinion | 24% Buy | 100% Buy | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -4.09% since 03/27/25 | -9.95% since 03/27/25 | -5.75% since 03/27/25 | ||
| Low | 17.87 on 03/31/25 | 55.37 on 04/02/25 | 37.46 on 04/01/25 | ||
| High | 20.63 on 03/28/25 | 64.41 on 03/28/25 | 43.69 on 04/02/25 | ||
| 1-Month | |||||
| %Chg | +22.87% since 03/03/25 | -11.94% since 03/03/25 | -5.53% since 03/03/25 | ||
| Low | 13.50 on 03/04/25 | 55.37 on 04/02/25 | 37.46 on 04/01/25 | ||
| High | 20.70 on 03/25/25 | 69.90 on 03/05/25 | 48.43 on 03/24/25 | ||
| 3-Month | |||||
| %Chg | +5.48% since 01/03/25 | +24.68% since 01/03/25 | -17.91% since 01/03/25 | ||
| Low | 13.50 on 03/04/25 | 43.44 on 01/10/25 | 37.46 on 04/01/25 | ||
| High | 20.70 on 03/25/25 | 70.40 on 03/03/25 | 52.80 on 01/27/25 | ||
| 6-Month | |||||
| %Chg | -0.61% since 10/03/24 | +88.54% since 10/03/24 | -27.27% since 10/03/24 | ||
| Low | 13.50 on 03/04/25 | 30.76 on 10/04/24 | 37.46 on 04/01/25 | ||
| High | 23.64 on 11/11/24 | 70.40 on 03/03/25 | 59.39 on 11/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 4,782,170 | 4,872,638 | 4,766,043 | ||
| Shares Outstanding, K | 236,390 | 80,820 | 118,411 | ||
| Annual Sales | 426,450,000 | 42,280,000 | 18,470,000 | ||
| Annual Net Income | 197,670,000 | -173,420,000 | -589,530,000 | ||
| Last Quarter Sales | 117,550,000 | 36,660,000 | 16,930,000 | ||
| Last Quarter Net Income | 111,900,000 | -33,830,000 | -150,020,000 | ||
| 60-Month Beta | 0.53 | 0.16 | 0.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.14 on 03/03/25 | -0.40 on 02/27/25 | -1.26 on 02/27/25 | ||
| Latest Earnings Date | 05/08/25 | 05/08/25 | 05/14/25 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 38.84 | 0.00 | 0.00 | ||